Pharmaceutical Firm Installs 9.95 MW Solar
KDC Solar commenced commercial operations of its 9.95- MW solar panel system in New Jersey. The system will provide electricity to Eli Lilly and Company’s ImClone biopharmaceutical operations in Branchburg, NJ.
The new system will generate nearly 12.9 million kWh per year. It will provide the primary Lilly manufacturing facility at this location with about 45 percent of its annual electricity needs. KDC Solar developed, owns and will operate the solar panel system.
KDC Solar signed an engineering and construction contract for the installation of the solar project with The Whiting-Turner Contracting Company and SPI Solar. Whiting-Turner was the general contractor, and SPI Solar provided solar panel procurement and oversight.
The solar panel system uses 40,180 PV panels, 16 Advanced Energy Industries 500 kilowatt inverters and is ground-mounted across 43 acres of land owned by a subsidiary of KDC Solar.
- The World Resources Institute Scope 2 Guidance: A Verifier’s Perspective
- Choosing the Correct Emission Control Technology
- Planning for a Sustainable Future
- How the IoT is Reshaping Building Automation
- Practical Insights into the Implementation of GHS Around the Globe
- Addressing Regulatory Trends with UVC LED-based Sensors
- 2015 Insider Knowledge
- Beyond Compliance: Applying a Risk Lens to Your EHS Practice
- The Missing Puzzle Piece: Automated Utility Data Aggregation
- Solar Request for Proposal (RFP) Guide